CLINICAL_TRIALS
trial_result
· 2012-11-05
Clinical Trial Update: Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML [Phase 3]
Summary
Phase 3 clinical trial comparing bosutinib to imatinib in newly diagnosed chronic phase Philadelphia chromosome–positive chronic myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2012-11-05